Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Result: 20% reduction in MACE (cardiovascular death, non-fatal MI, non-fatal stroke) versus placebo, the first MACE-reduction evidence for any GLP-1 compound in a non-diabetic population
Individual results vary based on health status, genetics, lifestyle, and other factors
For certain individuals, these medications may offer meaningful heart health benefits that go well beyond weight loss
Psychoneuroendocrinology 65:5466
IGF-1 LR3: Slightly Reduced but Sustained IGF-1R Engagement IGF-1 LR3, by contrast, has slightly reduced intrinsic affinity for IGF-1R compared to native IGF-1
Similarly, temporary changes in color or odor due to food choices are also normal
US$ 27.85
US$ 27.69
US$ 27.10
US$ 20.17
